ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 98 filers reported holding ENDOLOGIX INC in Q1 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $32,000 | -41.8% | 44,899 | 0.0% | 0.00% | -42.9% |
Q3 2018 | $55,000 | -54.2% | 44,899 | +2.3% | 0.01% | -58.8% |
Q2 2018 | $120,000 | -35.5% | 43,899 | 0.0% | 0.02% | -43.3% |
Q1 2018 | $186,000 | -14.7% | 43,899 | +7.7% | 0.03% | -16.7% |
Q4 2017 | $218,000 | +33.7% | 40,749 | +11.3% | 0.04% | -2.7% |
Q3 2017 | $163,000 | – | 36,599 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Capital Management, LLC | 4,000,000 | $68,280,000 | 9.00% |
Essex Woodlands Management, Inc. | 1,257,468 | $26,843,000 | 5.32% |
First Light Asset Management, LLC | 277,264 | $4,733,000 | 2.42% |
Lisanti Capital Growth, LLC | 175,060 | $2,988,000 | 1.70% |
ArrowMark Colorado Holdings LLC | 3,150,275 | $53,775,000 | 1.39% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,351 | $40,103,000 | 1.30% |
Rail-Splitter Capital Management, LLC | 186,076 | $3,176,000 | 0.97% |
WASHINGTON CAPITAL MANAGEMENT, INC | 82,316 | $1,405,000 | 0.81% |
Perceptive Advisors | 565,000 | $9,645,000 | 0.75% |
PALISADE CAPITAL MANAGEMENT, LP | 1,629,329 | $27,813,000 | 0.70% |